Pradhan; Nitin Sharad Chandra

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pradhan; Nitin Sharad Chandra.The latest application filed is for "esomeprazole strontium salt, process for its preparation and pharmaceutical compositions containing same".

Company Profile

0.7.15

Pradhan; Nitin Sharad Chandra - Thane IN
Pradhan; Nitin Sharad Chandra - Thane W
PRADHAN; Nitin Sharad Chandra - Maharashtra IN
Pradhan; Nitin Sharad Chandra - Manpada IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Amorphous and crystalline forms of aprepitant and processes for the preparation thereof Grant 9,227,958 - Sawant , et al. January 5, 2	2016-01-05
Process for the preparation of strontium ranelate Grant 8,624,041 - Kumar , et al. January 7, 2	2014-01-07
Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof Grant 8,097,729 - Sawant , et al. January 17, 2	2012-01-17
Process for the preparation of an optically active 5H-pyrrolo [3,4-B] pyrazine derivative Grant 7,863,273 - Pillai , et al. January 4, 2	2011-01-04
Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide Grant 7,649,096 - Kumar , et al. January 19, 2	2010-01-19
Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same App 20090298884 - Bhirud; Shekhar Bhaskar ; et al.	2009-12-03
Polymorphic Form of Lercanidipine Hydrochloride and Process for the Preparation Thereof App 20090221833 - Sawant; Mangesh Shivram ; et al.	2009-09-03
Process for the Preparation of Strontium Ranelate App 20090214631 - Kumar; Bobba Venkata Siva ; et al.	2009-08-27
Amorphous and Crystalline Forms of Aprepitant and Processes for the Preparation Thereof App 20090192161 - Sawant; Mangesh Shivram ; et al.	2009-07-30
Process For The Preparation of an Optically Active 5H-Pyrrolo [3,4-B] Pyrazine Derivative App 20090054441 - Pillai; Biju Kumar Gopinathen ; et al.	2009-02-26
Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation App 20070254941 - Kumar; Bobba Venkata Siva ; et al.	2007-11-01
Process for the preparation of tazarotene intermediates and use thereof for the preparation of tazarotene App 20070238881 - KUMAR; Bobba Venkata Siva ; et al.	2007-10-11
Novel crystalline forms of desloratadine and processes for their preparation App 20070135472 - Kumar; Bobba Venkata Siva ; et al.	2007-06-14
Crystalline forms of almotriptan and processes for their preparation App 20070112055 - Sridharan; Ramasubramanian ; et al.	2007-05-17
Amorphous rizatriptan benzoate App 20070105927 - Sridharan; Ramasubramanian ; et al.	2007-05-10
Substantially pure olmesartan medoxomil and processes for its preparation App 20070105923 - Kumar; Bobba Venkata Siva ; et al.	2007-05-10
Novel polymorph form M of mifepristone and process for its preparation App 20070105828 - Joshi; Narendra Shriram ; et al.	2007-05-10
Process for the preparation of amorphous form of neutral esomeprazole App 20070043085 - Kumar; Bobba Venkata Siva ; et al.	2007-02-22
Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4-(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide App 20070015753 - Kumar; Bobba Venkata Siva ; et al.	2007-01-18
Polymorphic form of olmesartan and process for its preparation App 20060281800 - Kumar; Bobba Venkata Siva ; et al.	2006-12-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.